Hyperkalemia
Showing 1 - 25 of 2,110
Dietary Fiber and Hyperkalemia in Dialysis Patients
Completed
- Hyperkalemia
- Hemolysis
- dietary fiber
-
Jinan, Shandong, ChinaQianfoshan Hospital
May 8, 2023
Hyperkalemia Trial in Alexandria (sodium zirconium cyclosilicate (SZC), sodium polystyrene sulfonate)
Not yet recruiting
- Hyperkalemia
- sodium zirconium cyclosilicate (SZC)
- sodium polystyrene sulfonate
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Sep 7, 2023
Hyperkalemia, Potassium Imbalance, Electrolyte Imbalance Trial in Seeb (Insulin regular, Dextrose 50, salbutamol)
Not yet recruiting
- Hyperkalemia
- +3 more
- Insulin regular
- +2 more
-
Seeb, Muscat, OmanSultan Qaboos University hospital
Sep 11, 2023
Hyperkalemia, Diminished Renal Excretion Trial in Montréal (Novel dietary approach focused on restricting the intake of highly
Not yet recruiting
- Hyperkalemia, Diminished Renal Excretion
- Novel dietary approach focused on restricting the intake of highly bioavailable potassium
- Traditional approach
-
Montréal, Quebec, CanadaCIUSSS du Nord-de-l'Île-de-Montréal
Nov 4, 2023
Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram
Enrolling by invitation
- Hyperkalemia
-
Rochester, MinnesotaMayo Clinic
Jun 29, 2022
Oral Resin for Treatment of Hyperkalemia in Chinese Renal
Not yet recruiting
- Hyperkalaemia
- (no location specified)
Jul 14, 2022
Sodium Zirconium Cyclosilicate, Hyperkalemia, Hyperparathyroidism, Secondary Trial (Sodium zirconium cyclosilicate)
Completed
- Sodium Zirconium Cyclosilicate
- +2 more
- Sodium zirconium cyclosilicate
- (no location specified)
May 16, 2022
Hyperkalemia Trial in United States (LOKELMA 5 GM Powder for Oral Suspension)
Recruiting
- Hyperkalemia
- LOKELMA 5 GM Powder for Oral Suspension
-
La Jolla, California
- +4 more
Sep 7, 2022
Hyperkalemia Trial in Ranica (Veltassa Oral Powder Product, Placebo)
Not yet recruiting
- Hyperkalemia
- Veltassa Oral Powder Product
- Placebo
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
Mar 29, 2023
Hyperkalemia, End Stage Renal Disease Trial in Durham (Patiromer Oral Powder Product)
Enrolling by invitation
- Hyperkalemia
- End Stage Renal Disease
- Patiromer Oral Powder Product
-
Durham, North CarolinaDaVita Dialysis Sites
Jun 10, 2022
Acute Hyperkalemia, Oral Potassium Binders Trial in Orange (Polyethylene Glycol 3350, Sodium Polystyrene Sulfonate Oral
Recruiting
- Acute Hyperkalemia
- Oral Potassium Binders
- Polyethylene Glycol 3350
- +3 more
-
Orange, CaliforniaUniversity of California, Irvine Medical Center
Nov 2, 2022
Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5, Hyperkalemia Trial in Stockholm (sodium zirconium cyclosilicate
Recruiting
- Chronic Kidney Disease stage4
- +2 more
- sodium zirconium cyclosilicate and healthy diet
-
Stockholm, SwedenKarolinska Institutet
Jan 16, 2023
Hyperkalemia, Hypokalemia Trial in Taipei (AI-enabled ECG-based Screening Tool)
Recruiting
- Hyperkalemia
- Hypokalemia
- AI-enabled ECG-based Screening Tool
-
Taipei, TaiwanNational Defense Medical Center
Nov 2, 2022
Long-term Management of Hyperkalemia in Chronic Kidney Disease
Recruiting
- Hyperkalemia
-
Kasugai, Aichi, Japan
- +25 more
Aug 10, 2022
Hyperkalemia Trial in Aleppo (Levalbuterol, Albuterol)
Recruiting
- Hyperkalemia
-
Aleppo, Aleppo Provice, Syrian Arab RepublicAleppo University Hospital
Dec 12, 2021
Hyperkalemia Trial in China, India (Sodium Zirconium Cyclosilicate 5g, Sodium Zirconium Cyclosilicate 10g, Placebo)
Completed
- Hyperkalemia
- Sodium Zirconium Cyclosilicate 5g
- +2 more
-
Beijing, China
- +31 more
Oct 11, 2022
Chronic Kidney Diseases, Hyperkalemia Trial in New York (Patiromer, Research Diet Menu)
Completed
- Chronic Kidney Diseases
- Hyperkalemia
- Patiromer
- Research Diet Menu
-
New York, New YorkNYU Langone Health
Nov 24, 2021
Hospitalized Heart Failure With Different Serum Potassium Levels
Completed
- Hyperkalemia
- +2 more
-
Shanghai, Shanghai, ChinaResearch Site
Aug 12, 2022
Chronic Kidney Diseases, Heart Failure With Reduced Ejection Fraction, Hyperkalemia Trial in London (Lokelma Oral Product)
Recruiting
- Chronic Kidney Diseases
- +4 more
- Lokelma Oral Product
-
London, United KingdomSt Georges, University of London
Feb 16, 2022
Hyperkalemia's Illness and Treatment Burden in Chronic Kidney
Completed
- Hyperkalemia
-
Nagoyashi, Aichi, Japan
- +4 more
Sep 6, 2021